Efficiency in different immunotherapy of cancer: literature review
It is known that the immune system plays one of the main roles in the development of oncology. This is confirmed by the fact that patients with congenital or acquired immunodeficiency have a higher risk of developing cancer. To date, there are several types of immunotherapy, each of which has its ow...
Main Authors: | K. A. Gaptulbarova, M. M. Tsyganov, M. K. Ibragimova, A. M. Pevzner, L. V. Spirina, N. V. Litviakov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2021-12-01
|
Series: | Успехи молекулярной онкологии |
Subjects: | |
Online Access: | https://umo.abvpress.ru/jour/article/view/385 |
Similar Items
-
Immunotherapy in patients with cervical cancer
by: A. G. Kedrova
Published: (2020-11-01) -
Interdisciplinary approach to the management of patients with uterine cancer progression
by: K. Yu. Morkhov, et al.
Published: (2022-05-01) -
The Debut of Inflammatory Musculoskeletal Pathology in Patients Receiving Anticancer Therapy with PD-1/PD-L1 Pathway Inhibitors
by: A. D. Koltakova, et al.
Published: (2022-10-01) -
Biomarkers for non-small cell lung cancer immunotherapy
by: D. A. Kharagezov, et al.
Published: (2021-09-01) -
Immune checkpoint inhibitors for the treatment of solid tumors in HIV-infected patients: is it worth the risk?
by: E. A. Degtiareva, et al.
Published: (2023-02-01)